Technical Analysis
Comprehensive insights into market trends, chart patterns, and key indicators. Equip yourself with the tools and strategies to make data-driven trading decisions.
The US dollar is on track for its strongest year since 2015, driven by a robust US economy and Federal Reserve policy. This strength contrasts with weakening global currencies, making the dollar an attractive investment.
Bank of England holds interest rates at 4.75%, leaving markets anticipating cuts in 2025. While cuts are expected to ease borrower pressures, the BoE remains cautious due to inflation and economic uncertainty.
Bank of England Holds Interest Rates Steady, Leaving Markets in Suspense Read More »
UK house prices ended 2024 up 4.7%, defying economic headwinds and exceeding expectations. While this resilience is positive, the 2025 outlook remains uncertain due to upcoming stamp duty changes and affordability challenges.
UK Housing Market Ends 2024 Strong, but 2025 Outlook Uncertain Read More »
UK property market outlook for 2025: Expert insights reveal promising areas for investment, from affordable northern markets to commuter towns and emerging London hotspots. Navigate the changing landscape with regional trends and predictions.
UK Property Market Outlook 2025: Expert Insights on Where to Buy Read More »
Stocks dipped midday Monday as investors await key inflation data due later this week. Mondelez’s potential Hershey takeover bid and activist pressure on Macy’s also made headlines.
US stocks dipped Tuesday as investors awaited the Federal Reserve’s interest rate decision. While a rate cut is expected, strong economic data has created uncertainty about the Fed’s future moves.
Fed Decision Looms: US Stock Market Dips in Anticipation of Rate Cut Read More »
European bond rally waning as ECB rate cuts are priced in. Australian bonds poised to outperform on likely RBA dovish shift and offer compelling investment opportunity.
Australian Bonds Poised for Outperformance as European Rally Wanes Read More »
Pfizer ends its hemophilia A gene therapy partnership with Sangamo, impacting the future of giroctocogene fitelparvovec. Despite positive Phase III results, market challenges led to Pfizer’s withdrawal, leaving Sangamo to seek new avenues for the promising therapy.
Pfizer Terminates Hemophilia A Gene Therapy Partnership with Sangamo Read More »
Taylor Swift’s Eras Tour grossed an estimated $2.2 billion, becoming the highest-grossing tour ever. Spanning five continents and 149 shows, it solidified Swift’s status as a global icon and redefined live entertainment.
Taylor Swift’s Eras Tour Shatters Records, Grossing an Estimated $2.2 Billion Read More »
Cyril Han becomes Ant Group’s CEO in March 2025, signaling a renewed focus on growth and innovation. This strategic shift follows regulatory challenges and positions the fintech giant for future expansion leveraging AI and technology.
Ant Group Appoints Cyril Han as New CEO, Signaling Growth Strategy Read More »
